Last reviewed · How we verify
Myelodysplastic syndrome
Approved treatments
- Reblozyl · EuroBloodNet Association
- Dacogen · Sun Pharma
Dacogen works by inhibiting the enzyme that adds methyl groups to DNA, which helps to restore normal gene function in cancer cells. - Inqovi · Otsuka
Inqovi works by blocking the enzyme cytidine deaminase, allowing chemotherapy medications to be more effective. - Vidaza · Bristol-Myers Squibb
Vidaza works by incorporating itself into DNA and interfering with the enzyme that adds methyl groups, which helps to restore normal gene function in cancer cells. - Dacogen · Mayo Clinic
- azacytidine · Assistance Publique Hopitaux De Marseille
- Revlimid · Bristol-Myers Squibb
Lenalidomide targets cereblon to degrade substrate proteins, inducing cytotoxicity and immunomodulation. - REBLOZYL · CELGENE CORP
- Reblozyl · Celgene Corp
Reblozyl works by binding to growth/differentiation factor 11, promoting the maturation of red blood cells. - Lenali · Singapore General Hospital
- Revlimid · M.D. Anderson Cancer Center
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Myelodysplastic syndrome patent landscape — cliff calendar, originator estates, attackable patents
- Myelodysplastic syndrome treatment landscape brief
- Myelodysplastic syndrome treatment updates RSS
Frequently asked questions about Myelodysplastic syndrome
What drugs treat Myelodysplastic syndrome?
Tracked treatments include Reblozyl, Dacogen, Inqovi, Vidaza, azacytidine, Revlimid, REBLOZYL, Lenali.
What is the treatment for Myelodysplastic syndrome?
Standard treatment for Myelodysplastic syndrome includes Reblozyl, Dacogen, Inqovi, Vidaza, azacytidine. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Myelodysplastic syndrome patent cliff · Myelodysplastic syndrome CI report
- Treatment: Reblozyl · EuroBloodNet Association
- Treatment: Dacogen · Sun Pharma
- Treatment: Inqovi · Otsuka
- Treatment: Vidaza · Bristol-Myers Squibb
- Treatment: Dacogen · Mayo Clinic
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing